Back | Next |
home / stock / sngx / sngx message board
Subject | By | Source | When |
---|---|---|---|
Time for a bounce? | fung_derf | investorshub | 04/12/2023 1:23:58 PM |
The trading | fung_derf | investorshub | 04/11/2023 12:10:54 PM |
Price gaining last trade up | fung_derf | investorshub | 04/08/2023 5:00:17 PM |
where is the squeeze? | BooDog | investorshub | 04/08/2023 3:15:16 AM |
$SNGX short squeeze signal | TruckingAngler | investorshub | 04/07/2023 8:36:01 PM |
$SNGX we got news | fung_derf | investorshub | 04/06/2023 7:41:08 PM |
just the news we needed | BooDog | investorshub | 04/06/2023 2:39:42 AM |
I don't think date for that meeting was | TruckingAngler | investorshub | 04/05/2023 7:51:04 PM |
whytestocks: $SNGX News Article - Soligenix Receives USAN Approval for Hypericin Sodium as Nonpropri | whytestocks | investorshangout | 04/05/2023 5:55:46 PM |
Waiting to see how the meeting goes with | BooDog | investorshub | 04/05/2023 4:16:41 PM |
When was the reverse split here? Did I | fung_derf | investorshub | 04/05/2023 2:50:30 PM |
$SNGX 4/05/2023 receives approval for HyBryte... | TruckingAngler | investorshub | 04/05/2023 2:32:12 PM |
MomentumIts gaining | TruckingAngler | investorshub | 04/04/2023 6:18:12 AM |
I never recommend penny stocks as a smart | fung_derf | investorshub | 03/01/2023 4:43:37 PM |
Someone willing to sell a FEW every day $SNGX | TruckingAngler | investorshub | 02/28/2023 4:29:05 PM |
$SNGX not many sells but $3.06 on bid | TruckingAngler | investorshub | 02/28/2023 12:05:53 PM |
I think this company is fraud. At | Cosa | investorshub | 02/18/2023 8:47:35 AM |
Apparently they suckered you in. Hope you didn't | fung_derf | investorshub | 02/14/2023 3:47:21 PM |
And now refused so $SNGX at .20 pre split | TruckingAngler | investorshub | 02/14/2023 1:56:21 PM |
They did their RS. And then.... SLAM!!! | BooDog | investorshub | 02/14/2023 1:11:19 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 10:20:00 ET July 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compa...
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView is pleased to announce an exclusive Q&A session with Dr. Ellen Kim, discussing the promising interim results of Soligenix's ( Nasdaq:SNGX ) HyBryte™ from the ongoing investigator-initiated study (IIS). HyBryte...